Live feed
Filing
SC 13G/A
SC 13G/A0001535610-16-000086·Oncotelic Therapeutics, Inc.
Schedule 13G ownership disclosure
OXIGENE INC
Security class unavailable · CUSIP: 691828107
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,196,500
- Percent of class
- 8.2700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-16-000086
- Form type
- SC 13G/A
- Filer
- Oncotelic Therapeutics, Inc.
- CIK
- CIK 908259
- Filed
- Jan 06, 2016
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership